Thought Leadership

IMP Labeling: EU CTR Transition Considerations

The blog post explores the critical aspects of transitioning Investigational Medicinal Product (IMP) labeling from the EU Clinical Trial Directive (EU CTD) to the new EU Clinical Trial Regulation (EU CTR). ...

Assessing Readiness for EU Clinical Trials Regulation (CTR): Five Points to Consider

Assessing Readiness for EU Clinical Trials Regulation (CTR): Five Points to Consider...

Leveraging the Patent Priority Date: A Life Sciences Focus

This TransPerfect Life Sciences blog post provides insights into the strategic importance of patent priority dates in the life sciences sector. ...